Abstract
The ability of the cancer cells to survive hostile environment depends on their cellular stress response mechanisms. These mechanisms also help them to develop resistance to chemotherapies. Autophagy and more specifically organelle specific autophagy is one such adaptive mechanism that promotes drug resistance in cancer cells. Endoplasmic reticulum–specific autophagy or ER-phagy has been more recently described to overcome ER-stress through the degradation of damaged ER. ER-resident proteins such as FAM134B act as ER-phagy receptors to specifically target damaged ER for degradation through autophagy. Moreover, we had recently deciphered that ER-phagy facilitates cancer cell survival during hypoxic stress and we predict that this process could play a critical role in the development of drug resistance in cancer cells. Therefore, here, we provide a lay description of how ER-phagy could be investigated biochemically by Western blot analysis and silencing ER-phagy receptor genes using small interfering RNAs (siRNA).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bahar E, Kim J-Y, Yoon H (2019) Chemotherapy resistance explained through endoplasmic reticulum stress-dependent signaling. Cancers 11(3):338
Anding AL, Baehrecke EH (2017) Cleaning house: selective autophagy of organelles. Dev Cell 41(1):10–22
White E, DiPaola RS (2009) The double-edged sword of autophagy modulation in cancer. Clin Cancer Res 15(17):5308–5316
Li Y-Y, Feun LG, Thongkum A, Tu C-H, Chen S-M, Wangpaichitr M, Wu C, Kuo MT, Savaraj N (2017) Autophagic mechanism in anti-cancer immunity: its pros and cons for cancer therapy. Int J Mol Sci 18(6):1297
White E (2012) Deconvoluting the context-dependent role for autophagy in cancer. Nat Rev Cancer 12(6):401–410
Mathew R, Karantza-Wadsworth V, White E (2007) Role of autophagy in cancer. Nat Rev Cancer 7(12):961–967
Rohwer N, Lobitz S, Daskalow K, Jöns T, Vieth M, Schlag P, Kemmner W, Wiedenmann B, Cramer T, Höcker M (2009) HIF-1α determines the metastatic potential of gastric cancer cells. Br J Cancer 100(5):772–781
Giatromanolaki A, Koukourakis M, Sivridis E, Turley H, Talks K, Pezzella F, Gatter K, Harris A (2001) Relation of hypoxia inducible factor 1 α and 2 α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival. Br J Cancer 85(6):881–890
Bos R, Van der Groep P, Greijer AE, Shvarts A, Meijer S, Pinedo HM, Semenza GL, Van Diest PJ, Van der Wall E (2003) Levels of hypoxia-inducible factor-1α independently predict prognosis in patients with lymph node negative breast carcinoma. Cancer 97(6):1573–1581
Hayashi-Nishino M, Fujita N, Noda T, Yamaguchi A, Yoshimori T, Yamamoto A (2009) A subdomain of the endoplasmic reticulum forms a cradle for autophagosome formation. Nat Cell Biol 11(12):1433–1437
Ylä-Anttila P, Vihinen H, Jokitalo E, Eskelinen E-L (2009) 3D tomography reveals connections between the phagophore and endoplasmic reticulum. Autophagy 5(8):1180–1185
Grumati P, Dikic I, Stolz A (2018) ER-phagy at a glance. J Cell Sci 131(17):jcs217364
Khaminets A, Heinrich T, Mari M, Grumati P, Huebner AK, Akutsu M, Liebmann L, Stolz A, Nietzsche S, Koch N (2015) Regulation of endoplasmic reticulum turnover by selective autophagy. Nature 522(7556):354–358
Grumati P, Morozzi G, Hölper S, Mari M, Harwardt M-LI, Yan R, Müller S, Reggiori F, Heilemann M, Dikic I (2017) Full length RTN3 regulates turnover of tubular endoplasmic reticulum via selective autophagy. Elife 6:e25555
Fumagalli F, Noack J, Bergmann TJ, Cebollero E, Pisoni GB, Fasana E, Fregno I, Galli C, Loi M, Soldà T (2016) Translocon component Sec62 acts in endoplasmic reticulum turnover during stress recovery. Nat Cell Biol 18(11):1173–1184
Smith MD, Harley ME, Kemp AJ, Wills J, Lee M, Arends M, von Kriegsheim A, Behrends C, Wilkinson S (2018) CCPG1 is a non-canonical autophagy cargo receptor essential for ER-phagy and pancreatic ER proteostasis. Dev Cell 44(2):217–232. e211
Chen Q, Xiao Y, Chai P, Zheng P, Teng J, Chen J (2019) ATL3 is a tubular ER-phagy receptor for GABARAP-mediated selective autophagy. Curr Biol 29(5):846–855. e846
An H, Ordureau A, Paulo JA, Shoemaker CJ, Denic V, Harper JW (2019) TEX264 is an endoplasmic reticulum-resident ATG8-interacting protein critical for ER remodeling during nutrient stress. Mol Cell 74(5):891–908. e810
Chino H, Hatta T, Natsume T, Mizushima N (2019) Intrinsically disordered protein TEX264 mediates ER-phagy. Mol Cell 74(5):909–921. e906
Delorme-Axford E, Popelka H, Klionsky DJ (2019) TEX264 is a major receptor for mammalian reticulophagy. Taylor & Francis, Oxfordshire
Nthiga TM, Kumar Shrestha B, Sjøttem E, Bruun JA, Bowitz Larsen K, Bhujabal Z, Lamark T, Johansen T (2020) CALCOCO 1 acts with VAMP-associated proteins to mediate ER-phagy. EMBO J 39(15):e103649
Bernales S, McDonald KL, Walter P (2006) Autophagy counterbalances endoplasmic reticulum expansion during the unfolded protein response. PLoS Biol 4(12):e423
Hübner CA, Dikic I (2020) ER-phagy and human diseases. Cell Death Differ 27(3):833–842
Islam F, Gopalan V, AKY L (2018) RETREG1 (FAM134B): a new player in human diseases: 15 years after the discovery in cancer. J Cell Physiol 233(6):4479–4489
Chipurupalli S, Ganesan R, Martini G, Mele L, Reggio A, Esposito M, Kannan E, Namasivayam V, Grumati P, Desiderio V, Robinson N (2022) Cancer cells adapt FAM134B/BiP mediated ER-phagy to survive hypoxic stress. Cell Death Dis 13(4):357
Acknowledgments
Research in NR’s laboratory is supported by funds from Centre for Cancer Biology, University of South Australia, and the Neurosurgical Research Foundation (NRF), Australia. The authors also acknowledge the support to SC from Department of Science and Technology, Government of India (SR/WOS-A/LS-21/2016) under Women Scientist Scheme. The authors also acknowledge that the graphical representations were created with BioRender.com.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Chipurupalli, S., Desiderio, V., Robinson, N. (2022). Analysis of ER-Phagy in Cancer Drug Resistance. In: Baiocchi, M. (eds) Cancer Drug Resistance. Methods in Molecular Biology, vol 2535. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2513-2_16
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2513-2_16
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2512-5
Online ISBN: 978-1-0716-2513-2
eBook Packages: Springer Protocols